Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Colorado, Denver
About this trial
The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.
Eligibility criteria
Qualifiers
Age 18 - 60
For women, premenopausal status
Disqualifiers
Active cardiovascular or pulmonary disease (e.g. hypertension, coronary artery disease, cardiomyopathy, arrhythmia, valvular abnormalities, diabetes, peripheral vascular disease, tobacco use, chronic obstructive pulmonary disease, asthma, interstitial lung disease, restrictive lung disease, or pulmonary hypertension)
Use of cardiac- or pulmonary-related medications
Prior history of high altitude pulmonary edema or high altitude cerebral edema
Body mass index < 18.5 or > 30
Trial design
Treatments tested in this trial
- Ferrous sulfate 325mg
Treatment groups
5 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov